WO2015182530A1 - Substance indigeste et son procédé de fabrication - Google Patents

Substance indigeste et son procédé de fabrication Download PDF

Info

Publication number
WO2015182530A1
WO2015182530A1 PCT/JP2015/064835 JP2015064835W WO2015182530A1 WO 2015182530 A1 WO2015182530 A1 WO 2015182530A1 JP 2015064835 W JP2015064835 W JP 2015064835W WO 2015182530 A1 WO2015182530 A1 WO 2015182530A1
Authority
WO
WIPO (PCT)
Prior art keywords
spore
dietary fiber
indigestible
spores
indigestible substance
Prior art date
Application number
PCT/JP2015/064835
Other languages
English (en)
Japanese (ja)
Inventor
一典 三輪
公子 南田
Original Assignee
アテリオ・バイオ株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アテリオ・バイオ株式会社 filed Critical アテリオ・バイオ株式会社
Priority to JP2016523477A priority Critical patent/JP6306170B2/ja
Publication of WO2015182530A1 publication Critical patent/WO2015182530A1/fr

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
    • Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
    • Y02P60/87—Re-use of by-products of food processing for fodder production

Definitions

  • the present invention relates to an indigestible substance excellent in improving the intestinal environment and a method for producing the same.
  • probiotics In order for microorganisms effective for improving the intestinal environment, called probiotics, to reach the lower gastrointestinal tract, especially the large intestine, after ingestion, gastric acid with a strong bactericidal action and food in the small intestine Must be resistant to exposure to various substances involved in digestion and absorption.
  • Bacillus coagulans a spore-forming lactic acid bacterium
  • Bacillus coagulans a spore-forming lactic acid bacterium
  • Spores of spore-forming lactic acid bacteria show high resistance to the surrounding environment, but the spore that has reached the environment suitable for growth, for example, the digestive tract below the stomach, germinates and changes into vegetative cells. Loses resistance to Butyric acid bacteria have similar problems.
  • microorganisms that are used as probiotics including spore bacteria useful for humans such as spore-forming lactic acid bacteria and butyric acid bacteria, as well as microorganisms that do not have various resistances or are insufficient.
  • spore bacteria useful for humans such as spore-forming lactic acid bacteria and butyric acid bacteria
  • microorganisms that do not have various resistances or are insufficient.
  • formulation-like devices that can provide the desired resistance exogenously.
  • the probiotics have a characteristic of proliferating predominately over other intestinal bacteria in the intestinal environment where a very wide variety of microorganisms are mixed to form a flora.
  • a formulation ingenuity that can provide such growth characteristics exogenously, that is, can provide a favorable growth environment for the desired probiotics, can also be effective for improving the intestinal environment using probiotics.
  • Patent Document 1 discloses an intracolon pressure collapse type colon delivery capsule using ethyl cellulose.
  • capsule technology using such a polymer film is mainly for the purpose of drug delivery, and it is disadvantageous in terms of cost in providing useful substances such as probiotics and prebiotics in the form of food.
  • problems such as reducing the stability of probiotics and prebiotics, which are objects, in the formulation process.
  • Patent Document 2 discloses frozen bread containing lactic acid bacteria. Moreover, the stabilization method of the spore using a specific emulsifier and thickening polysaccharide is disclosed. However, even though these techniques can maintain the spore state before ingestion orally, the spore germinates in the small intestine after ingestion and changes to vegetative cells, resulting in the necessary amount in the large intestine, etc. There remains a risk that the spores or sporic lactic acid bacteria could not be delivered. Furthermore, these techniques do not improve the growth characteristics of spore-forming lactic acid bacteria in the large intestine.
  • the present invention improves the intestinal environment suitable for use in the form of food, allowing probiotics to reach a desired location in the intestine, especially the distal large intestine, and promote its growth at such location.
  • An object of the present invention is to provide an indigestible substance having excellent effects and a method for producing the same.
  • the present inventors have completed the following inventions while variously examining probiotic protection means using dietary fiber.
  • the dietary fiber is fine powdered okara having a particle diameter of 200 ⁇ m or less, cellulose, or a derivative thereof.
  • the saccharide and protein or amino acid are cereal grains or a processed product thereof.
  • the processed grain product is soybean flour, rice flour or barley extract.
  • the mixture further comprises prebiotics.
  • a therapeutic agent for irritable bowel syndrome comprising the indigestible substance according to any one of (6) to (9) as an active ingredient.
  • a useful substance having an action to improve the intestinal environment represented by probiotics is efficiently delivered to the distal part of the large intestine and proliferated to improve the intestinal environment in the distal part of the large intestine. can do.
  • bowel movements can be improved to promote proper defecation, and continuous ingestion can prevent repeated diarrhea and constipation seen in irritable bowel syndrome.
  • 6 is a graph showing the growth of the indigestible substance and spore-forming lactic acid bacteria produced in Examples 3 to 5 in a pseudo-distal colon environment. The cecum excised from the rat fed with the indigestible substance produced in Example 2 and the indigestible substance reaching the cecum (location indicated by ⁇ in the figure) are shown.
  • the present invention relates to an indigestible substance comprising a step of preparing a mixture comprising dietary fiber, spore fungus and / or spore thereof, sugar, and protein or amino acid, and a step of forming melanoidin by heating the mixture.
  • a manufacturing method is provided.
  • Examples of dietary fiber in the present invention include pure dietary fiber, water-soluble dietary fiber such as indigestible dextrin, water-insoluble dietary fiber such as cellulose, fruit peel, cereal bran, bran, okara, or vegetable (A food material containing the above-mentioned dietary fiber obtained by refining or grinding a water-insoluble solid content after squeezing fruit (including moss and beans) or fruits can also be used. Many of these dietary fiber-containing food materials contain a small amount of saccharides and / or proteins derived from raw materials, and therefore are advantageous dietary fibers in the present invention in forming melanoidins described later.
  • water-soluble dietary fiber such as indigestible dextrin
  • water-insoluble dietary fiber such as cellulose, fruit peel, cereal bran, bran, okara
  • vegetable A food material containing the above-mentioned dietary fiber obtained by refining or grinding a water-insoluble solid content after squeezing fruit (including
  • the dietary fiber-containing food material that can be used in the present invention includes “Beat fiber” (http://www.nitten.co.jp/product/fiber.html, water-insoluble dietary fiber of beet) manufactured by Nippon Sugar Sugar Co., Ltd. “PURE FIBER” from Fi Nutrition Co., Ltd. (http://www.fi-nutrition.jp/product/product01_01.html, water-insoluble dietary fibers such as wheat, oats, and sugarcane) And so on “(http://3maru.co.jp/sanchemifa/q.seni.htm, water-insoluble dietary fiber of corn).
  • Particularly preferable dietary fiber-containing materials in the present invention include fine powdered okara containing water-insoluble dietary fiber, for example, having a particle diameter of 200 ⁇ m or less, preferably 150 ⁇ m or less.
  • the pulverized okara having various particle sizes including the fine okara having the above particle size is already on the market, and in the present invention, a commercially available fine okara may be used.
  • a normal okara that has not been pulverized is used as a raw material, a pulverization process or a crushing process known to those skilled in the art is performed, and a product prepared by sieving using a sieve of 100 mesh size or more is referred to in the present invention. You may use as fine powder Okara.
  • cellulose or a derivative thereof is cellulose or a derivative thereof.
  • Cellulose can be used as long as it is taken orally, and cellulose powder, particularly microcrystalline cellulose, which is widely used as a food additive or a pharmaceutical excipient, is preferred.
  • Microcrystalline cellulose is an example of a water-insoluble dietary fiber, and examples include Theolas (registered trademark) UF, ST or FD grade of Asahi Kasei Corporation, KC Flock (registered trademark) of Nippon Paper Group.
  • the cellulose derivative should just be ingestible orally, and hydroxypropyl methylcellulose, carboxymethylcellulose, etc. can be utilized.
  • Spores are generally bacteria that can form durable spores when placed in an unfavorable environment for growth, but in the present invention, they are resistant to digestion and have excellent effects on improving the intestinal environment. Because it aims to provide a substance, spore bacteria are limited to those useful for the intestinal environment. Such spore bacteria beneficial to the human intestinal environment include sporic lactic acid bacteria (reference: Yuichi Makiura, “FOOD Style 21”, 2002, 6, 9, pp. 77-80) and butyric acid bacteria. Is mentioned.
  • sporic lactic acid bacteria examples include Bacillus coagulans, Sporolactobacillus inulinus, and the like.
  • B. Coagulance is commercially available under names such as Lacris (registered trademark) -S. In the present invention, B.I.
  • the use of a coagulance strain is preferred.
  • the use of the coagulance lilac-01 strain is preferred.
  • the lilac-01 strain is described in Japanese Patent No. 5006986, and is deposited at the National Institute of Technology and Evaluation Microorganisms Deposit Number: NITE P-1102.
  • Clostridium butyricum ( Clostridium butyricum ) can be mentioned as an example of a butyric acid bacterium.
  • C. Butyricum is marketed under a name such as Miyabae.
  • Spores of spore bacteria useful in the intestinal environment are prepared by performing known treatments that can form spores on vegetative cells of spore bacteria, such as heating, drying, and addition of chemicals. be able to. Conveniently, it can be prepared by heating or drying a medium in which spore bacteria are grown.
  • saccharide in the present invention examples include monosaccharides, disaccharides, oligosaccharides, and polysaccharides having a reducing end, combinations thereof, or mixtures containing them.
  • the saccharide may be added to the mixture separately from other raw materials, or may be a saccharide derived from a dietary fiber-containing food material or a protein raw material described below.
  • proteins include plant proteins and / or animal proteins.
  • cereal grains containing both saccharides and proteins or processed products thereof examples include soybean powder, oryza protein (registered trademark, reference URL: http://www.oryza.co.jp/product/detail/oryza_protein_igai.html) manufactured by Oriza Oil Co., Ltd., or Ozeki Co., Ltd.
  • Indigestible rice proteins such as profiber (reference URL: http://www.ozeki.co.jp/food_bio/jyozo2.html), fermented barley extract from Sanwa Sake Co., Ltd.
  • potato protein such as the use of soybean flour or indigestible rice protein is more preferable.
  • the amino acid is not particularly limited as long as it is an amino acid capable of forming melanodine, or may be an amino acid contained in the dietary fiber-containing food material.
  • the method of the present invention includes a step of preparing a mixture by mixing the dietary fiber, spore fungus and / or spore thereof, saccharide, protein or amino acid, respectively described above.
  • saccharides may be prepared separately from other ingredients, but originally included when using dietary fiber-containing food materials or when using grains or processed products thereof as proteins. It may be a saccharide derived from a raw material.
  • the moisture may be added to the mixture independently of dietary fiber, spore fungus and / or its spore, saccharide and protein or amino acid, or may contain dietary fiber, spore fungus and / or its spore, saccharide and protein or amino acid. It may be brought into the mixture as water used for wetting or a solution or suspension containing these.
  • the amount ranges from the amount that gives moisture enough to knead the mixture of dietary fiber, spore fungus and / or spore, saccharide, and protein or amino acid without scattering the powder, and the amount from which the mixture becomes pasty. It is preferable to adjust as appropriate.
  • the mixing amount ratio between the saccharide and the protein or amino acid in the mixture can be set according to the number of functional groups contributing to the Maillard reaction contained therein, that is, the reducing end of the saccharide and the amino group of the protein or amino acid,
  • the ratio of sugar: protein or amino acid is appropriately adjusted within a range of about 0.1: 10 to 10: 0.1, or 1: 5 to 5: 1, or 0.5: 1 to 1: 0.5. It is preferable to do.
  • the mixing ratio of dietary fiber to saccharide and protein or amino acid is 500: 1 to 1: 5, preferably 500: 1 to 1, with the ratio of dietary fiber: saccharide and protein or amino acid being the weight ratio excluding moisture. It is preferable to adjust appropriately within the range of: 1.
  • dietary fiber-containing materials used as dietary fiber for example, fine okara itself or cereals or processed products thereof originally contain sugars and / or proteins or amino acids
  • the content of sugars, proteins or amino acids for each raw material may be adjusted within the above range by specifying the amount and taking these into consideration.
  • Difficulty in the indigestible substance finally produced by adjusting the amount of saccharide and protein or amino acid in the mixture in consideration of the content of saccharide and / or protein or amino acid contained in dietary fiber as raw material The content of digestible carbohydrates (resistant carbohydrate, abbreviated as RC) and / or indigestible proteins (resistant protein, abbreviated as RP) can be adjusted.
  • Probiotics which are microorganisms that contribute to the improvement of the intestinal environment, each have a content ratio of carbohydrate (C) and protein (P) suitable for their dominant growth. It is not considered to adjust or control the content ratio (C / P ratio) of quality (C) and protein (P), particularly the ratio of RC and RP (RC / RP ratio).
  • the method of the present invention produces an indigestible substance having a C / P ratio suitable for the growth of spore bacteria and further an RC / RP ratio by appropriately adjusting or controlling the C / P ratio in the mixture. Can do.
  • the number of spores and / or the number of spores contained in the mixture is determined in consideration of the preferred daily intake per adult for each spore fungus (generally said to be about 1 million to 1 billion). You just have to decide. For example, approximately 10,000 to 10 billion, preferably 100,000 to 1 billion spores and / or spores of the same number of spores per unit weight (gram) of the indigestible substance. Spores or vegetative cells of 10 to 100 times these spores may be contained in the mixture. However, the number of spores and / or spores contained in the mixture is not limited to the above range. It is possible within the scope of the methods disclosed herein to prepare a lesser or greater amount of spore bacteria and / or an indigestible material comprising the spores.
  • spore bacteria are prepared by suspending fine powdered okara and peptone or cereal flour such as soybean flour, resistant rice protein or barley extract in an appropriate amount of water. This is a step of mixing a culture solution obtained by culturing for an appropriate time.
  • the present invention further includes a step of forming melanoidin by heating the mixture.
  • Melanoidin is a brown product produced by a reaction between a protein or amino acid and a reducing sugar, that is, a Maillard reaction (also referred to as an aminocarbonyl reaction), and is a reaction product that is commonly found in cooking and the like.
  • the heating in the present invention may be performed until the mixture turns brown over an appropriate temperature and time, and special methods and conditions, and no special equipment are required for the temperature and time. Specifically, depending on the amount of the mixture and the water content, the degree of browning and the dry state are appropriately confirmed at a temperature in the range of about 80 ° C. to 150 ° C., preferably 90 ° C. to 120 ° C. for 10 minutes to 120 minutes.
  • the mixture may be heated while heating.
  • Examples of the method of heating the mixture in the present invention include a method of heating the mixture while winding it with high-temperature hot air, a method of heating the mixture by exposure to infrared or radiant heat while stirring, and as necessary.
  • Examples of the method include frying the mixture while stirring, but are not limited thereto.
  • a preferable heat treatment method in the present invention is a method in which the mixture is fried while stirring the mixture on or in a suitable container. In particular, in the present invention, it is preferable to further perform a drying treatment with or after heating.
  • the melanoidin formed by heating is melanoidin formed between sugars and / or proteins or amino acids contained in dietary fiber and other components in the mixture, and when the dietary fiber itself has a reducing end. Mention may be made of melanoidins formed between the reducing end and the protein or amino acid in the mixture. In the case of this melanoidin, the dietary fiber itself is converted into merinosin. Melanoidin can also be formed between components other than dietary fiber. In the case of this melanoidin, it adheres to the dietary fiber so as to burn, and does not easily leave the dietary fiber. Thus, in the present invention, the state in which the dietary fiber itself is melanoidized or the melanoidin adheres to the dietary fiber and does not leave easily is expressed as being adhered to the dietary fiber.
  • the spore bacteria after heating and / or the spores are sandwiched between dietary fiber and melanoidin adhering thereto, embedded in melanoidin adhering to dietary fiber, spores and food Melanoidin is formed between the fiber and integrated with dietary fiber, or is fixed to dietary fiber as melanoidin formed between spore and saccharide and / or protein or amino acid It is guessed.
  • the state in which the spore bacteria and / or the spores thereof are not easily separated from the dietary fiber is expressed in the present invention as the spore bacteria and / or the spores are fixed to the dietary fiber.
  • the mixture before a heating contains the vegetative cell of a spore bacteria, it is guessed that many form a durable spore in the middle of a heating, and this spore adheres to a dietary fiber.
  • the indigestible substance produced by the method of the present invention is such that the dietary fiber itself is melanoidized by including other components and spore bacteria, or the spores and melanoidins of spore bacteria cannot be easily separated.
  • adhering to dietary fiber i.e., spore and melanodine fixed to dietary fiber, and in a mere mixture of dietary fiber, spores of spore fungi and melanoidin.
  • the mixture in the production method of the present invention may contain dietary fiber, spore fungus and / or spore thereof, saccharide, and any useful substance other than protein or amino acid as long as it does not interfere with the formation of melanoidin by heating.
  • the useful substance can be fixed to the dietary fiber by adding the useful substance to the mixture.
  • a typical example of a useful substance in the present invention is a so-called prebiotic that selectively promotes the growth of useful intestinal bacteria including spore bacteria.
  • Indigestible substances produced via a mixture further containing prebiotics are useful as synbiotics containing probiotics and prebiotics simultaneously.
  • Prebiotics include disaccharides such as turanose, cellobiose and lactulose, panose, gentianose, melezitose, stachyose, galactooligosaccharide, fructooligosaccharide, soybean oligosaccharide, dairy oligosaccharide, xylooligosaccharide, isomaltoligosaccharide, raffinose, mannan oligo Sugar, nigerooligosaccharide, cellooligosaccharide, maltotriose, cyclodextrin, oligosaccharide such as coffee bean manno-oligosaccharide, organic acid such as gluconic acid, polydextrose, inulin, guar gum degradation product, soluble dietary fiber such as psyllium, rice starch, There may be mentioned starches such as shinshin flour, shiratama flour, corn starch, potato starch, rice flour and brown rice
  • nutritional aspects such as amino acids, vitamins, minerals, etc., provided that the formation of melanoidin and the growth of spore bacteria in the distal large intestine are not hindered.
  • An effective substance or an effective substance generally regarded as a food functional ingredient may be added to the mixture and fixed to the dietary fiber.
  • the present invention further provides an indigestible substance obtained by adhering spores of spore bacteria and melanoidin to dietary fiber.
  • dietary fiber and its particle diameter, spores of spore bacteria and the term “adherence” are as described above.
  • the content of dietary fiber, saccharides, protein, and spores of spore bacteria contained in the indigestible substance may be within a range determined by the use amount described in the above production method.
  • the indigestible substance of the present invention contains various substances such as pharmacologically effective substances and nutritionally effective substances in addition to the prebiotics described above in dietary fiber in the same form as spores. As described above, it may be fixed. That is, a typical or suitable example of the indigestible substance of the present invention is an indigestible substance produced by the method of the present invention.
  • the indigestible substance of the present invention can be in any form such as block, granule or powder.
  • the mixture in the present invention described above may be put into a suitable mold and heated to form a lump, or after forming melanoidin, a suitable binder or binder is added and processed into a suitable mold. It is good also as a lump.
  • the mixture can be heated to a granular or powdery indigestible substance by heating with stirring, or a product processed into a lump shape may be pulverized or crushed into a granular or powdery indigestible substance.
  • the indigestible substance of the present invention is effective in improving the intestinal environment, particularly in the distal part of the large intestine.
  • the dietary fiber, spore-forming spore and melanoidin contained in the indigestible substance of the present invention are all resistant to degradation in the stomach internal environment and the small intestine internal environment, and thus ingested the indigestible substance. It is expected to be protected from digestion and absorption by the host itself. At the same time, the protective action by dietary fiber and melanoidin is expected to prevent the spores of spore bacteria from transforming into vegetative cells in the stomach and small intestine.
  • the decomposition of the indigestible substance of the present invention is finally started in earnest under the internal environmental conditions of the large intestine. Most of the spores of the spore bacteria fixed by this decomposition are released. In addition, the dietary fiber to which the spore has adhered and the melanoidin itself or its degradation product, which has adhered to the spore, become a germination inducer of spore bacteria and / or a nutrient source for cell growth. And the growth of spore bacteria begins.
  • the indigestible substance of the present invention passes through the stomach and intestine of the host ingesting it almost without being decomposed and reaches the proximal part of the large intestine.
  • the spores of spore bacteria are released throughout the large intestine, especially at the distal end where degradation proceeds, and melanodine or its degradation products are supplied as nutrients. It is expected to change the spore to a vegetative cell and promote the dominant growth of spore bacteria in the distal large intestine.
  • lactic acid bacteria and butyric acid bacteria are known as probiotics effective for improving the intestinal environment.
  • the conventional intestinal preparations using these probiotics regard the entire large intestine as one gastrointestinal tract having the same environment, and it is not considered to maintain an optimal fermentation state for each large intestine region.
  • butyric acid bacteria are formulated in the above-mentioned intestinal preparation in a so-called naked state, and it is not sufficient to consider the ability to reach the large intestine, particularly the distal part of the large intestine.
  • the bowel movement improving effect of conventional intestinal preparations specifically the effect of improving constipation, constipation-like or diarrhea-prone, or soft stool-like bowel movements, is not always satisfactory.
  • the indigestible substance of the present invention promotes the production of an appropriate amount of lactic acid in the intestine, particularly in the distal part of the large intestine, based on the above characteristics, and further by converting butyric acid from this lactic acid, or butyric acid itself. It is expected that peristaltic movement of the intestine is induced by promoting the generation, and appropriate defecation can be promoted. An appropriate amount of butyric acid also favors normal renewal of colonic epithelial cells and prevention of colorectal cancer.
  • the indigestible substance of the present invention can stably maintain the improved environment by continuous ingestion, thereby allowing the irritable intestine to remain stable. It is expected to prevent repeated diarrhea and constipation seen in the syndrome.
  • the indigestible substance of the present invention may be ingested as it is, suspended in a suitable beverage such as water, fruit juice, milk, soy milk or mixed with bread, white rice, cereal or other foods, or cookies, cakes, You may take in the form of processed foods such as bread.
  • a suitable beverage such as water, fruit juice, milk, soy milk or mixed with bread, white rice, cereal or other foods, or cookies, cakes.
  • the indigestible substance of the present invention may be used in the form of health supplements, supplements or pharmaceuticals produced as one of raw materials, and these are various raw materials and additives usually used by those skilled in the art.
  • Other substances and the indigestible substance of the present invention can be combined in an appropriate form and produced according to a usual method.
  • the intake of the indigestible substance of the present invention can be determined as appropriate according to the spore bacteria and / or the number of spores contained per unit weight of the indigestible substance.
  • the preferred intake of spore bacteria is said to be 1 million to 1 billion per day for adults, and it is sufficient to consume an indigestible substance in an amount that can provide a number in this range.
  • the effective intake of dietary fiber and melanoidin 1 mg to 1000 g per day, preferably 0.1 g to 1000 g, more preferably 1 g to
  • the intake amount of the indigestible substance of the present invention may be adjusted in the range of 100 g, more preferably 1 to 10 g.
  • Example 1> B Coagulance lilac-01 strain was inoculated into 100 mL (pH 7.0) of a medium containing 0.5% peptone SE 50M, 0.5% yeast extract, 0.5% glucose, 0.1% magnesium sulfate and 5 ppm manganese sulfate. Spore culture was carried out at 40 ° C. for 2 days to form spores. After centrifugation, the cells were washed once with sterile physiological saline and then suspended in sterile physiological saline.
  • the spore suspension (200 ⁇ L) was added to a soybean powder suspension obtained by adding 100 mL of distilled water to 5 g of soybean powder (Minami Sangyo Co., Ltd.), and 200 g of fine powder Okara (Kikkoman Beverage Co., Ltd.) was added and mixed.
  • the indigestible substance of the present invention was produced by heating and drying 100 g of this mixture in a frying pan for 8 minutes.
  • the number of spores of the lilac-01 strain per 1 g of the indigestible substance was 4.0 ⁇ 10 2 .
  • Example 2> B The coagulance lilac-01 strain was inoculated into 4 L of soy milk (Kikkoman Beverage Co., Ltd.) and cultured with shaking at 55 ° C. for 24 hours. After the cultivation, 4 kg of fine powder Okara (Kikkoman Beverage Co., Ltd.) was added and mixed. 10 g of this mixture was taken as a control product, and the remaining 4 kg was transferred to a kneader (manufactured by Samsung Corp.), followed by heating and drying at 120 ° C. for 20 minutes. After drying, it is passed through a sieve of analytical sieve (mesh No.
  • Example 1 1) Test in simulated proximal colon environment model The indigestible substance produced in Example 1 was crushed with a lab miller (LAB CAT) and processed into a powder form. Spores of lilac-01 strain (1 ml of medium) suspended in physiological saline as a control in medium (pH 6.5) containing peptone SE 50M 0.25%, yeast extract 0.1% and magnesium sulfate 0.1% And 20 g of the above powdery indigestible substance (containing 20 spores per 1 ml of medium), and anaerobically cultivated at 37 ° C. Number was measured. The result is shown in FIG.
  • the growth of the lilac-01 strain reaches the logarithmic growth phase 15 hours after the start of the culture and reaches the equilibrium phase after 24 hours, whereas in the examples, it germinates and grows later than the control. confirmed.
  • the control spore did not germinate, and the growth of the fungus was not confirmed.
  • a growth curve as shown in FIG. 4 was shown. From this, it was confirmed that the spores of spore-forming lactic acid bacteria included in the Examples germinate in the pseudo-distal colon environment and can grow using the components contained in the indigestible substance as a nutrient source.
  • the substances were added so that the number of spores was 20 per 1 ml of the medium, respectively, and anaerobically cultured at 37 ° C., and the number of living bacteria of the lilac-01 strain was examined over time. This culture is for confirming the proliferation ability in the pseudo proximal colon environment. The result is shown in FIG.
  • control product and the digestible substance of Example 2 which were further washed with physiological saline once after artificial digestion treatment in 5 mL of 0.85% sterilized physiological saline, each had 3 ⁇ 10 spores per 1 ml of physiological saline.
  • anaerobic culture was performed at 37 ° C., and the viable count of lilac-01 strain was examined over time. This culture is for confirming the proliferative ability in the pseudo-distal colon environment. The result is shown in FIG.
  • the indigestible substance of the present invention reaches the large intestine and germinates later in the pseudo proximal colon environment than in the control product, and in the pseudo distal colon environment than in the control product. It was confirmed that the growth rate was large.
  • Example 3> B The coagulance lilac-01 strain was inoculated into 100 mL (pH 7.0) of a medium containing 0.5% peptone, 0.5% yeast extract, 0.5% glucose, 0.1% magnesium sulfate and 5 ppm manganese sulfate. And cultured for 2 days with shaking to form spores. After centrifugation, the cells were washed once with sterile physiological saline and then suspended in sterile physiological saline. The previous spore suspension (20 ⁇ L) was added to 30 mL of 5% sterilized soybean powder suspension, and 15 g of finely divided cellulose (Asahi Kasei Chemicals Corporation) was added and mixed.
  • Example 4> B The coagulance lilac-01 strain was inoculated into 100 mL (pH 7.0) of a medium containing 0.5% peptone, 0.5% yeast extract, 0.5% glucose, 0.1% magnesium sulfate and 5 ppm manganese sulfate. And cultured for 2 days with shaking to form spores. After centrifugation, the cells were washed once with sterile physiological saline and then suspended in sterile physiological saline.
  • the spore suspension (20 ⁇ L) was added to a solution obtained by adding 20 mL of distilled water to 2.0 g of peptone and 11.0 g of honey, and further 15 g of finely divided cellulose (Asahi Kasei Chemicals Corporation) was added and mixed. This mixture was heated and dried in a frying pan for 5 minutes, passed through an analytical sieve (mesh No. 24, the size of the stitch was 0.71 mm), and the portion that did not pass through (the size of the grain was 1-2 mm). By recovering, the indigestible substance of the present invention was produced. The number of spores of lilac-01 strain per gram of the indigestible substance was 1.3 ⁇ 10 2 .
  • Example 5> B The coagulance lilac-01 strain was inoculated into 100 mL (pH 7.0) of a medium containing 0.5% peptone, 0.5% yeast extract, 0.5% glucose, 0.1% magnesium sulfate and 5 ppm manganese sulfate. And cultured for 2 days with shaking to form spores. After centrifugation, the cells were washed once with sterile physiological saline and then suspended in sterile physiological saline. The spore suspension (20 ⁇ L) was added to 30 mL of a solution containing 0.5% peptone and 0.5% glucose, and 15 g of sodium carboxymethyl cellulose (Nippon Paper Industries Co., Ltd.) was added and mixed.
  • ⁇ Test Example 2 > 2 of Test Example 1) 0.5 g of indigestible substance produced in Examples 3 to 5 (including 13 to 20 spores per 1 ml of physiological saline) according to the test in the pseudo-distal colon environment model As a control, spore of lilac-01 strain (400 per 1 ml of physiological saline) suspended in physiological saline was added to 5 mL of 0.85% sterile physiological saline (pH 7.0), followed by anaerobic culture at 37 ° C. The viable count of lilac-01 strain was measured over time. The result is shown in FIG.
  • the control spore did not germinate and the growth of lilac-01 strain was not confirmed.
  • the lilac-01 strain exhibited a growth curve as shown in FIG. Therefore, spores of spore-forming lactic acid bacteria contained in the indigestible substances produced in Examples 3 to 5 germinate in the pseudo-distal colon environment and proliferate using the ingredients contained in the indigestible substances as nutrients. Confirmed that you can.
  • Example 3 WKAH / HkmSlc rats (5-week-old male, approximately 120 g body weight) were preliminarily raised, and then a feed mixed with the indigestible substance produced in Example 2 (5 ⁇ 10 6 spore bacteria per gram of feed) was freely ingested. However, it was raised for 2 weeks. After breeding, the animals were dissected and the cecum was removed and the contents were observed (FIG. 8). As a result, it was confirmed that a number of indigestible substances (locations indicated by ⁇ in the figure) reached the cecum without being digested.
  • Example 5 SD-type Slc rats (5-week-old male, approximately 120 g body weight) were preliminarily raised and divided into 2 groups.
  • the control group contained only sporic lactic acid bacteria (1 ⁇ 10 6 spore bacteria per gram of feed). Were reared for 2 weeks while freely ingesting the feed containing the indigestible substance produced in Example 2 (1 ⁇ 10 6 spores per gram of feed).
  • the cecum was dissected after breeding and the number of viable spore-forming lactic acid bacteria in the cecal contents was smeared on a standard agar medium (Nissui Pharmaceutical) after dilution and measured after aerobic culture at 55 ° C for 1 day. .
  • the number of spores of spore-forming lactic acid bacteria was measured by taking a 10-fold diluted solution in a microtube, heating at 90 ° C. for 10 minutes, and then culturing in the same manner. When the germination rate was calculated from these values, it was confirmed that the germination rate of the control group was 6% and that of the test group was 29%.
  • Example 6 WKAH / HkmSlc rats (5-week-old male, body weight: about 120 g) were preliminarily raised, and then freely fed with a diet containing indigestible substances produced in Example 2 (5 ⁇ 10 6 spores per gram of feed). Reared for 2 weeks. The cecum was dissected after breeding and the cecal contents were taken out, and the concentration of short-chain fatty acids in the cecal contents was measured with an organic acid measurement HPLC (LC-10ADvp; Shimadzu Corporation).
  • short-chain fatty acids are known to improve the intestinal environment and have therapeutic effects on inflammatory bowel diseases such as ulcerative colitis.
  • Butyrate is particularly useful for the treatment of irritable bowel syndrome. It is known to be effective (eg, Zateski et al., Przegrad Gastroenterology, 2013, Vol. 8, pages 350-353). Therefore, it is considered that the indigestible substance of the present invention is also effective as a therapeutic agent for intestinal regulating agent, inflammatory bowel disease or irritable bowel syndrome.
  • the present invention is useful for improving the intestinal environment, particularly the intestinal environment in the distal part of the large intestine, and can promote proper defecation, as well as prevent repeated diarrhea and constipation seen in irritable bowel syndrome.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Fodder In General (AREA)
  • Beans For Foods Or Fodder (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

[Problème] L'invention a pour objectif de concevoir une substance indigeste qui permet d'administrer des probiotiques au côlon distal et qui a un effet remarquable d'amélioration du milieu intestinal, et un procédé de fabrication de la substance indigeste. [Solution] La présente invention concerne un procédé de fabrication d'une substance indigeste, le procédé comprenant : une étape consistant à préparer un mélange qui contient des fibres alimentaires, des bactéries sporulées et/ou leurs spores, un sucre et une protéine ou un acide aminé; et une étape consistant à chauffer le mélange afin de former des mélanoïdines. Il est ainsi possible d'obtenir une substance indigeste qui permet d'améliorer l'évacuation des selles et de favoriser une défécation convenable, ainsi que d'éviter les épisodes de diarrhée et de constipation répétés associés au syndrome du côlon irritable par le biais d'une ingestion continue.
PCT/JP2015/064835 2014-05-24 2015-05-24 Substance indigeste et son procédé de fabrication WO2015182530A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2016523477A JP6306170B2 (ja) 2014-05-24 2015-05-24 難消化性物質及びその製造方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014107626 2014-05-24
JP2014-107626 2014-05-24

Publications (1)

Publication Number Publication Date
WO2015182530A1 true WO2015182530A1 (fr) 2015-12-03

Family

ID=54698861

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2015/064835 WO2015182530A1 (fr) 2014-05-24 2015-05-24 Substance indigeste et son procédé de fabrication

Country Status (2)

Country Link
JP (1) JP6306170B2 (fr)
WO (1) WO2015182530A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210138002A1 (en) * 2018-06-15 2021-05-13 University Of Tasmania Preparation for the treatment of inflammatory bowel disease using a whole plant fibre extract from sugarcane

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6394948A (ja) * 1986-10-09 1988-04-26 Yakult Honsha Co Ltd 食物繊維の製造法
JPH02222658A (ja) * 1989-01-06 1990-09-05 Alko Ab Oy 穀物繊維およびその製造法
JPH06298650A (ja) * 1993-04-16 1994-10-25 Asahi Chem Ind Co Ltd 経管流動食
JP2003102426A (ja) * 2001-09-28 2003-04-08 Hosoda Shoten:Kk 栄養補助食品
JP2006325486A (ja) * 2005-05-26 2006-12-07 Akira Matsuo 機能性食品および機能性飲料
JP2007507209A (ja) * 2003-10-01 2007-03-29 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガナイゼイション プロバイオティクスの保存と送達
JP2013133423A (ja) * 2011-12-27 2013-07-08 Tropical Plant Resources Institute Inc 抗酸化剤および抗酸化飲料

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0404152A (pt) * 2004-09-17 2006-06-13 Unicamp alimento funcional, composição probiótica, composição alimentìcia e processo de produção de alimento funcional fermentado a base de soja, contendo agentes probióticos e prebióticos

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6394948A (ja) * 1986-10-09 1988-04-26 Yakult Honsha Co Ltd 食物繊維の製造法
JPH02222658A (ja) * 1989-01-06 1990-09-05 Alko Ab Oy 穀物繊維およびその製造法
JPH06298650A (ja) * 1993-04-16 1994-10-25 Asahi Chem Ind Co Ltd 経管流動食
JP2003102426A (ja) * 2001-09-28 2003-04-08 Hosoda Shoten:Kk 栄養補助食品
JP2007507209A (ja) * 2003-10-01 2007-03-29 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガナイゼイション プロバイオティクスの保存と送達
JP2006325486A (ja) * 2005-05-26 2006-12-07 Akira Matsuo 機能性食品および機能性飲料
JP2013133423A (ja) * 2011-12-27 2013-07-08 Tropical Plant Resources Institute Inc 抗酸化剤および抗酸化飲料

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NAOTO SHIMIZU ET AL.: "New Food Materials by Fermentation of Indica Type Rice, Pulse and Tofu-byproduct : Production of dosa · okara dosa", JOURNAL OF THE BREWING SOCIETY OF JAPAN, vol. 100, no. 4, 2005, pages 224 - 229, XP055240973 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210138002A1 (en) * 2018-06-15 2021-05-13 University Of Tasmania Preparation for the treatment of inflammatory bowel disease using a whole plant fibre extract from sugarcane

Also Published As

Publication number Publication date
JPWO2015182530A1 (ja) 2017-04-20
JP6306170B2 (ja) 2018-04-04

Similar Documents

Publication Publication Date Title
Topping et al. Resistant starch as a prebiotic and synbiotic: state of the art
Patel et al. The current trends and future perspectives of prebiotics research: a review
Charalampopoulos et al. Application of cereals and cereal components in functional foods: a review
CN102770155B (zh) 包含谷物基部分和益生菌的非发酵组合物及其用途
CN105594811B (zh) 一种无麸质木薯营养饼干及其制备方法
WO2007114378A1 (fr) Composition destinée à une boisson ou à un aliment
WO2013114048A1 (fr) Produits de cuisson ne contenant pas de gluten
US20070275038A1 (en) Food and feed compositions including resistant starch
JP2002533107A (ja) 食品および薬剤製造用α−アミラーゼ耐性デンプン
CN107251988A (zh) 合生素产品
KR20010101531A (ko) 개선된 미생물 제제
JP2021513869A (ja) 排便誘導及びダイエット用組成物とその製造方法
CN106879846A (zh) 一种保育仔猪专用配合饲料小料及其制备方法
Knudsen et al. In vivo methods to study the digestion of starch in pigs and poultry
Bao et al. Structural characteristics and prebiotic effects of Semen coicis resistant starches (type 3) prepared by different methods
CN112450252A (zh) 一种增强饱腹感的代餐冷加工糕点及其制备方法
CN112352874A (zh) 一种抗仔猪腹泻益生菌制剂及其制备方法
EP2031975A1 (fr) Procédé d'enrobage et de libération ciblée de micro nutriments dans des fibres diététiques activées
El-Mahis et al. How does rye compare to other cereals? A comprehensive review of its potential nutritional value and better opportunities for its processing as a food-based cereal
JP6306170B2 (ja) 難消化性物質及びその製造方法
Brown et al. Resistant starch: plant breeding, applications development and commercial use
Rendón‐Villalobos et al. Proximal composition and in vitro starch digestibility in flaxseed‐added corn tortilla
CN106689756B (zh) 一种提高断奶仔猪食欲和消化功能的饲料添加剂及其制备方法与应用
CN107950864A (zh) 一种合生元谷蔬代餐粉及其制备方法和应用
CN110251474B (zh) 一种淀粉基大肠靶向双层益生菌片的制备方法

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15799798

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2016523477

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15799798

Country of ref document: EP

Kind code of ref document: A1